Lumanity will be attending and presenting during the 2026 conference.
Panel:
Global Trends and Reality Checks on the State of Cancer Research
Cancer research is at a crossroad with many of the new political, social and policy changes evolving ahead on top of the historical challenges to this ecosystem. Conversely, we see disrupters such as AI and other technologies positively accelerating the impact on cancer research ahead. This panel will call out those significant headwinds and tailwinds ahead for cancer researchers and investors in the years ahead.
Moderator: Anthony Barisano, Vice President, Global HEOR, Bristol Myers Squibb
Faculty:
- Murray Aitken, Executive Director, IQVIA Institute for Human Data Science and Visiting Professor in Practice, The London School of Economics and Political Science
- John Doyle, DrPH, Head of Medical Evidence Generation, Pfizer
- Jeff Bockman, PhD, EVP & Expert Advisor, Oncology, Lumanity
- Charlotte Mosser, Chief Medical Officer, Parexel
Schedule time to meet with us by reaching out to contact@lumanity.com.